特宝生物(688278)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

688278 特宝生物

已收盘 07-22 15:00:00

{"stockData":{"symbol":"688278","market":"SH","secType":"STK","nameCN":"特宝生物","latestPrice":76.52,"timestamp":1753167600000,"preClose":78.2,"halted":0,"volume":2906045,"delay":0,"changeRate":-0.0215,"floatShares":407000000,"shares":407000000,"eps":2.1655,"marketStatus":"已收盘","change":-1.68,"latestTime":"07-22 15:00:00","open":78.19,"high":78.19,"low":76,"amount":224000000,"amplitude":0.028,"askPrice":76.57,"askSize":6,"bidPrice":76.52,"bidSize":2,"shortable":0,"etf":0,"ttmEps":2.1655,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1753234200000},"marketStatusCode":5,"adr":0,"adjPreClose":78.2,"symbolType":"stock_kcb","openAndCloseTimeList":[[1753147800000,1753155000000],[1753160400000,1753167600000]],"highLimit":86.02,"lowLimit":70.38,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":406800000,"isCdr":false,"pbRate":11.32,"roa":"--","peRate":35.33595,"roe":"6.86%","epsLYR":2.03,"committee":-0.762376,"marketValue":31128000000,"turnoverRate":0.0071,"status":1,"afterMarket":{"amount":0,"volume":0,"close":76.52,"buyVolume":0,"sellVolume":0,"time":1753169638018,"indexStatus":"已收盘 07-22 15:30:00","preClose":78.2},"floatMarketCap":31128000000},"requestUrl":"/m/hq/s/688278","defaultTab":"news","newsList":[{"id":"2552417769","title":"每周股票复盘：特宝生物（688278）发生大宗交易，审议通过资金使用议案","url":"https://stock-news.laohu8.com/highlight/detail?id=2552417769","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552417769?lang=zh_cn&edition=full","pubTime":"2025-07-20 05:30","pubTimestamp":1752960632,"startTime":"0","endTime":"0","summary":"截至2025年7月18日收盘，特宝生物报收于75.45元，较上周的75.79元下跌0.45%。本周关注点交易信息汇总：7月18日特宝生物发生1笔大宗交易，成交金额500.23万元公司公告汇总：审议通过《关于使用自有资金支付募投项目所需资金并以募集资金等额置换的议案》交易信息汇总7月18日特宝生物发生1笔大宗交易，成交金额500.23万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025072000001319.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688278","BK0239"],"gpt_icon":0},{"id":"2552466866","title":"7月18日特宝生物发生1笔大宗交易 成交金额500.23万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2552466866","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552466866?lang=zh_cn&edition=full","pubTime":"2025-07-18 17:20","pubTimestamp":1752830434,"startTime":"0","endTime":"0","summary":"证券之星消息，7月18日特宝生物发生大宗交易，交易数据如下：大宗交易成交价格75.45元，成交6.63万股，成交金额500.23万元，买方营业部为国泰海通证券股份有限公司总部，卖方营业部为广发证券股份有限公司厦门湖滨南路证券营业部。近三个月该股共发生17笔大宗交易，合计成交6.1万手，折价成交6笔。该股近期无解禁股上市。截至2025年7月18日收盘，特宝生物报收于75.45元，下跌1.58%，换手率0.54%，成交量2.19万手，成交额1.66亿元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025071800027638.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688278","BK0239"],"gpt_icon":0},{"id":"2551929399","title":"【机构调研记录】华安基金调研特宝生物、上海港湾等4只个股（附名单）","url":"https://stock-news.laohu8.com/highlight/detail?id=2551929399","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551929399?lang=zh_cn&edition=full","pubTime":"2025-07-14 08:01","pubTimestamp":1752451290,"startTime":"0","endTime":"0","summary":"证券之星消息，根据市场公开信息及7月11日披露的机构调研信息，华安基金近期对4家上市公司进行了调研，相关名单如下：1）特宝生物 调研纪要：特宝生物在机构调研中表示，公司始终以解决未被满足的临床需求为核心，聚焦免疫与代谢领域，致力于为重大疾病治疗提供更优解决方案。派格宾联合核苷（酸）类似物增加适应症上市许可申请于2024年3月获得受理。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025071400001896.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688278","605598","BK0239","BK0277"],"gpt_icon":0},{"id":"2551919326","title":"每周股票复盘：特宝生物（688278）长效生长激素市场策略明确，派格宾销售趋势积极","url":"https://stock-news.laohu8.com/highlight/detail?id=2551919326","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551919326?lang=zh_cn&edition=full","pubTime":"2025-07-13 03:30","pubTimestamp":1752348629,"startTime":"0","endTime":"0","summary":"截至2025年7月11日收盘，特宝生物报收于75.79元，较上周的71.9元上涨5.41%。本周，特宝生物7月11日盘中最高价报76.52元。机构调研要点问：长效生长激素的市场销售策略？答：派格宾联合核苷（酸）类似物适用于临床治愈成人慢性乙型肝炎的增加适应症上市许可申请于2024年3月份获得国家药监局受理，目前处于技术审评阶段，项目进展公司将根据有关规定及时履行信息披露义务。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025071300000606.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688278","BK0239"],"gpt_icon":0},{"id":"2550339099","title":"特宝生物：7月10日接受机构调研，中欧基金、华泰证券等多家机构参与","url":"https://stock-news.laohu8.com/highlight/detail?id=2550339099","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550339099?lang=zh_cn&edition=full","pubTime":"2025-07-11 17:01","pubTimestamp":1752224500,"startTime":"0","endTime":"0","summary":"证券之星消息，2025年7月11日特宝生物发布公告称公司于2025年7月10日接受机构调研，中欧基金、华泰证券、华安基金参与。目前项目累计临床治愈率高于 40%，表明乙肝临床治愈的优势人群正持续扩大。特宝生物2025年一季报显示，公司主营收入6.73亿元，同比上升23.48%；归母净利润","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025071100027352.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0183","06886","LU1064130708.USD","BK0188","BK0012","LU1934453819.USD","LU1328615791.USD","BK0239","BK0028","LU1979443071.USD","LU1064131003.USD","BK1147","LU1781817850.SGD","601688","LU2148510915.USD","BK0276","BK1564","LU1580142542.USD","688278"],"gpt_icon":0},{"id":"2550605650","title":"独家药品概念盘中拉升，特宝生物涨7.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2550605650","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550605650?lang=zh_cn&edition=full","pubTime":"2025-07-11 09:48","pubTimestamp":1752198485,"startTime":"0","endTime":"0","summary":"07月11日，独家药品概念盘中拉升，截至09点48分，独家药品概念整体指数上涨1.07%，报964.640点。从个股上来看，该概念的成分股中，特宝生物涨7.01%，艾迪药业、广誉远、ST葫芦娃涨幅居前。从资金上来看，截止发稿，独家药品概念概念主力净流入为-558.41万，其中广誉远受到资金热捧，主力净流入1507.93万；拉长时间线来看，该板块近20日主力资金净流入-29.50亿。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250711094805953e2072&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250711094805953e2072&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688278","BK0239","605199","688488","BK0077","BK0188","600771"],"gpt_icon":0},{"id":"2550060591","title":"特宝生物涨5.01% 创新药国际化打开成长天花板","url":"https://stock-news.laohu8.com/highlight/detail?id=2550060591","media":"智选洞察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550060591?lang=zh_cn&edition=full","pubTime":"2025-07-11 09:41","pubTimestamp":1752198101,"startTime":"0","endTime":"0","summary":"特宝生物股价今日表现强势，截至09点40分，该股上涨5.01%，最新价报73.59元/股。医药板块整体承压成为主要诱因，中证医疗指数动态市盈率处于近五年13%分位，资金在防御属性与成长弹性间反复权衡。从估值角度看，当前33.98倍动态市盈率较生物制品行业仍存折价，资金面与技术面的博弈或将延续。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250711094152a6a29d52&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250711094152a6a29d52&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688278","159992","BK0239"],"gpt_icon":0},{"id":"2550472988","title":"通化东宝：完成特宝生物股权转让","url":"https://stock-news.laohu8.com/highlight/detail?id=2550472988","media":"财通证券","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550472988?lang=zh_cn&edition=full","pubTime":"2025-07-11 00:00","pubTimestamp":1752163200,"startTime":"0","endTime":"0","summary":"事件：7 月4 日，公司发布公告，完成了与西藏信托有限公司的股份协议转让。转让价款总额为13.01 亿元。本次转让占特宝生物总股本的5.70%。经过此次转让后，公司持特宝生物股总数由6520 万股减少至4201 万股，持股比例由16.03%降至10.33%；而西藏信托则新增持股2319 万股，占5.70%。本次转让将增厚公司的现金储备。在口服小分子GLP-1 受体激动剂领域，通化东宝正在进行THDBH110 的I 期临床试验。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250711135623a6a30a1d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250711135623a6a30a1d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["600867","BK0196","688278","BK0188","BK0239"],"gpt_icon":0},{"id":"2550610028","title":"7月10日特宝生物发生1笔大宗交易 成交金额402.96万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2550610028","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550610028?lang=zh_cn&edition=full","pubTime":"2025-07-10 17:20","pubTimestamp":1752139240,"startTime":"0","endTime":"0","summary":"证券之星消息，7月10日特宝生物发生大宗交易，交易数据如下：大宗交易成交价格70.08元，成交5.75万股，成交金额402.96万元，买方营业部为国泰海通证券股份有限公司总部，卖方营业部为广发证券股份有限公司厦门湖滨南路证券营业部。近三个月该股共发生16笔大宗交易，合计成交6.03万手，折价成交6笔。该股近期无解禁股上市。截至2025年7月10日收盘，特宝生物报收于70.08元，上涨0.19%，换手率0.26%，成交量1.07万手，成交额7487.83万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025071000027397.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688278","BK0239"],"gpt_icon":0},{"id":"2549543072","title":"特宝生物：公司将继续坚持以客户为中心提供更优质的产品和服务","url":"https://stock-news.laohu8.com/highlight/detail?id=2549543072","media":"互动易","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549543072?lang=zh_cn&edition=full","pubTime":"2025-07-08 17:45","pubTimestamp":1751967902,"startTime":"0","endTime":"0","summary":"有投资者向特宝生物提问， 董秘，您好！作为小股东和产品使用者，很高兴能与公司决策层互动。特宝免费送智能注射笔，智能笔的笔盒，又好看又结实，充电线的位置设计的很清爽。智能药液盒很有科技感，把它往智能笔上一插就能打，我家的青少年家属第一次见到它，就能痛快地自己去实施注射，没有反感。特宝还赠送浪费的药液（瓶内所剩，比处方剂量多出来的）。被特宝在细节处的用心感动，我会复购怡培长效生长激素并关注公司发展。公司回答表示，您好，感谢您对公司的关注和支持，公司将继续坚持以客户为中心，以患者需求为导向，提供更优质的产品和服务。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250708175843a69cec4c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250708175843a69cec4c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688278","BK0239"],"gpt_icon":0},{"id":"2549548352","title":"特宝生物：指创新药上市销售","url":"https://stock-news.laohu8.com/highlight/detail?id=2549548352","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549548352?lang=zh_cn&edition=full","pubTime":"2025-07-08 17:33","pubTimestamp":1751967185,"startTime":"0","endTime":"0","summary":"证券之星消息，特宝生物(688278)07月08日在投资者关系平台上答复投资者关心的问题。投资者提问：公司与九天生物约定的销售里程碑事件，是指腺相关病毒载体技术服务还是指创新药的销售？特宝生物回复：您好，指创新药上市销售，感谢您的关注。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025070800028656.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","159992","06978","BK1161","BK1574","688278"],"gpt_icon":0},{"id":"2549424643","title":"每周股票复盘：通化东宝（600867）转让特宝生物5.70%股份完成过户","url":"https://stock-news.laohu8.com/highlight/detail?id=2549424643","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549424643?lang=zh_cn&edition=full","pubTime":"2025-07-06 03:36","pubTimestamp":1751744173,"startTime":"0","endTime":"0","summary":"截至2025年7月4日收盘，通化东宝报收于8.07元，较上周的8.0元上涨0.88%。本次协议转让前后，通化东宝持股总数由65200114股变为42012514股，持股比例由16.03%变为10.33%，西藏信托持股总数由0股变为23187600股，持股比例由0%变为5.70%。通化东宝关于董事会秘书离任公告指出，通化东宝药业股份有限公司董事会近日收到董事会秘书苏璠女士递交的书面辞职报告，苏璠女士因个人原因申请辞去公司董事会秘书职务，辞职后不再担任公司任何职务。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025070600000394.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","600867","688278","BK0196","BK0239"],"gpt_icon":0},{"id":"2549315101","title":"特宝生物新提交5件商标注册申请","url":"https://stock-news.laohu8.com/highlight/detail?id=2549315101","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549315101?lang=zh_cn&edition=full","pubTime":"2025-07-05 05:58","pubTimestamp":1751666306,"startTime":"0","endTime":"0","summary":"证券之星消息，根据天眼查APP数据显示，近日厦门特宝生物工程股份有限公司新提交5件商标注册申请。商标申请详情如下：今年以来厦门特宝生物工程股份有限公司新申请注册商标10件，截止目前公司共持有注册商标236件，另有46件商标尚在注册申请中。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025070500005260.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688278","BK0239"],"gpt_icon":0},{"id":"2548380519","title":"特宝生物新提交1件商标注册申请","url":"https://stock-news.laohu8.com/highlight/detail?id=2548380519","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548380519?lang=zh_cn&edition=full","pubTime":"2025-07-04 05:06","pubTimestamp":1751576789,"startTime":"0","endTime":"0","summary":"证券之星消息，根据天眼查APP数据显示，近日厦门特宝生物工程股份有限公司新提交1件商标注册申请。商标申请详情如下：今年以来厦门特宝生物工程股份有限公司新申请注册商标5件，截止目前公司共持有注册商标236件，另有41件商标尚在注册申请中。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025070400003396.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688278"],"gpt_icon":0},{"id":"2548867768","title":"7月2日特宝生物发生1笔大宗交易 成交金额405.38万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2548867768","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548867768?lang=zh_cn&edition=full","pubTime":"2025-07-02 17:20","pubTimestamp":1751448042,"startTime":"0","endTime":"0","summary":"证券之星消息，7月2日特宝生物发生大宗交易，交易数据如下：大宗交易成交价格72.39元，成交5.6万股，成交金额405.38万元，买方营业部为国泰海通证券股份有限公司总部，卖方营业部为广发证券股份有限公司厦门环岛东路证券营业部。近三个月该股共发生19笔大宗交易，合计成交8.33万手，折价成交6笔，溢价成交4笔。该股近期无解禁股上市。截至2025年7月2日收盘，特宝生物报收于72.39元，下跌0.96%，换手率0.28%，成交量1.16万手，成交额8391.34万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025070200027958.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688278","BK0239"],"gpt_icon":0},{"id":"2548948835","title":"6月以来获融资净买入额居前的创新药概念股出炉","url":"https://stock-news.laohu8.com/highlight/detail?id=2548948835","media":"E公司","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548948835?lang=zh_cn&edition=full","pubTime":"2025-07-02 07:25","pubTimestamp":1751412316,"startTime":"0","endTime":"0","summary":"人民财讯7月2日电，今年以来，中国创新药产业迎来多项突破性进展。业内人士认为，目前中国创新药进入成果兑现阶段，研发进展催化较多，有望持续成为2025年医药板块投资主线。二级市场表现方面，据证券时报·数据宝统计，截至7月1日收盘，年内Wind创新药指数上涨超26%，创新药概念股今年以来平均上涨35%，大幅跑赢同期上证指数。资金面上，据数据宝统计，6月以来融资净买入超1亿元的创新药概念股有15只。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250702072516953320fa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250702072516953320fa&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688278","BK0239","600276","688166","159992"],"gpt_icon":0},{"id":"2547015164","title":"中国创新药能否持续让世界买单？券商分析师最新观点","url":"https://stock-news.laohu8.com/highlight/detail?id=2547015164","media":"券商中国","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2547015164?lang=zh_cn&edition=full","pubTime":"2025-06-30 23:29","pubTimestamp":1751297340,"startTime":"0","endTime":"0","summary":"医药魔方统计，2025年1—5月，中国创新药企对外授权交易总金额已达455亿美元，超过2024年上半年的交易总额，创新药出海授权交易大爆发。亮眼数据的背后，是中国创新药整体水平的强势崛起。“中国创新药产业的研发、临床与生产能力，正处于与国际一线水平接轨的初始阶段。”由于BD数据不及预期，年内大涨明显的创新药企业荣昌生物股价近期大幅回调，从而带动创新药板块整体调整。华泰柏瑞恒生创新药ETF6月中旬以来一度单周下行超过8%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250630233154a7267585&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250630233154a7267585&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["600380","600222","600513","600557","603567","ONC","600535","603087","159992","600351","688177","600200","688317","603707","688505","600062","600422","600080","688117","600332","688235","600420","600721","603590","688136","BK0239","600521","688166","688488","603229","688222","603259","688091","688073","688278","688331","688321","601607","600056","600276","600682","688336","600196","688513","603998","688189","603127","688131","688181","06160","600881","688202","688356","688319","600774","600789","600867","603367","600079","600572","688520","605199","600216","688163","600998","601089","603716","688506","688198","600851","688068","603456","600645","600267"],"gpt_icon":0},{"id":"2547602340","title":"医药生物行业2025年度中期投资策略：创新为王，出海扬帆","url":"https://stock-news.laohu8.com/highlight/detail?id=2547602340","media":"东海证券","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2547602340?lang=zh_cn&edition=full","pubTime":"2025-06-30 18:07","pubTimestamp":1751278055,"startTime":"0","endTime":"0","summary":"2024年国内创新药IND申报数为1425项，2025年1-5月国产创新药新上市数量为25个，国产占比持续提升；2025年ASCO会议中国药企大放异彩，超过15家国内药企贡献70余项研究成果，行业整体从“模仿追赶”向“引领超越”转变。需求端：我国创新药企licenseout交易数量快速增长，研发实力被全球认可，2024年跨国MCN引进的创新药中已有31%的产品来自中国。2025年以来，抗体药物licenseout数量24笔，涉及交易首付款金额17亿美元，总金额达301亿美元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025063018075795311ef3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025063018075795311ef3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688278","163118","688331","BK0239","000808.SH"],"gpt_icon":0},{"id":"2547161064","title":"特宝生物：评估派格宾联合ALG-000184治疗慢性乙型肝炎患者的疗效与安全性","url":"https://stock-news.laohu8.com/highlight/detail?id=2547161064","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2547161064?lang=zh_cn&edition=full","pubTime":"2025-06-30 17:24","pubTimestamp":1751275455,"startTime":"0","endTime":"0","summary":"投资者提问：董秘您好，快一年没见面了，请问一下贵公司和Aligos合作的ALG-000184，药监局受理号JXHB2500067，是单药试验还是和贵公司的联合用药项目呢，我查阅了贵公司的年报和季报，并没有关于跟Aligos合作临床的任何信息披露，可以介绍一下现阶段于Aligos的合作进展吗特宝生物回复：您好！公司于2024年7月22日与Aligos达成临床试验合作协议，根据协议条款，公司将在中国发起并开展一项Ⅰb期探索性临床研究，评估派格宾联合ALG-000184治疗慢性乙型肝炎患者的疗效与安全性。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025063000023281.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688278","BK0239"],"gpt_icon":0},{"id":"2547640230","title":"特宝生物：公司将在中国发起并开展一项Ⅰb期探索性临床研究","url":"https://stock-news.laohu8.com/highlight/detail?id=2547640230","media":"互动易","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2547640230?lang=zh_cn&edition=full","pubTime":"2025-06-30 17:24","pubTimestamp":1751275441,"startTime":"0","endTime":"0","summary":"公司于2024年7月22日与aligos达成临床试验合作协议，根据协议条款，公司将在中国发起并开展一项Ⅰb期探索性临床研究，评估派格宾联合ALG-000184治疗慢性乙型肝炎患者的疗效与安全性。目前项目相关工作正推进中，后续有关进展公司将严格按照相关法律法规和规范性文件的要求履行信息披露义务，感谢您的关注。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250630172613a725c7c8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250630172613a725c7c8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688278"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1753217807222,"stockEarnings":[{"period":"1week","weight":0.0145},{"period":"1month","weight":0.1151},{"period":"3month","weight":0.0501},{"period":"6month","weight":-0.0456},{"period":"1year","weight":0.3492},{"period":"ytd","weight":0.0517}],"compareEarnings":[{"period":"1week","weight":0.0219},{"period":"1month","weight":0.0661},{"period":"3month","weight":0.0866},{"period":"6month","weight":0.1089},{"period":"1year","weight":0.2084},{"period":"ytd","weight":0.0686}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"厦门特宝生物工程股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"7468人(较上一季度增加20.20%)","perCapita":"54472股","listingDate":"2020-01-17","address":"福建省厦门市海沧区新阳工业区翁角路330号","registeredCapital":"40680万元","survey":"　　厦门特宝生物工程股份有限公司的主营业务是重组蛋白质及其长效修饰药物研发、生产和销售。公司的主要产品是派格宾、珮金、特尔立、特尔津、特尔康。公司深耕免疫及代谢领域，践行以临床价值需求为导向，坚持以创新驱动发展，现已获得国家高新技术企业认定，建有国家级企业博士后科研工作站和国家地方联合工程研究中心。","listedPrice":8.24},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.3","shortVersion":"4.34.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"特宝生物(688278)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供特宝生物(688278)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"特宝生物,688278,特宝生物股票,特宝生物股票老虎,特宝生物股票老虎国际,特宝生物行情,特宝生物股票行情,特宝生物股价,特宝生物股市,特宝生物股票价格,特宝生物股票交易,特宝生物股票购买,特宝生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"特宝生物(688278)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供特宝生物(688278)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}